$1.5 billion
Just on the catalyst of oncology, allergy and hiv.
Mr. Kempers has skillfully expanded and added company value with oncology, allergy, covid19 as legs of the octopus to go along with the established malaria, hiv and influenza.
He doesn't need a homerun; just a single like he had with Astellas to get the pps moving. Then it will be in better position to reach dollar range on LOI.
His wife's work history includes Global Manufacturing Site Communications Manager for GSK. Manufacturing Communications Manager for Novartis. Currently, Director Global Communications Biosimilars for Fresenius-Kabi Biosimilars.
The Kempers family are good people and well connected.
The lack of communication is comical but I've enjoyed watching the progress of what he's built over the years.
Second generation on covid19 is the wildcard.
News 
Market Data 
Discover 
